Koray KARABULUT, Mehmet SARAC, Nidal İFLAZOĞLU, Serdar GURSUL

Parameters associated with survival in patients undergoing surgical treatment due to rectal cancer

Aim: Colorectal cancer is the third most common type of cancer.Approximately 1/3 of colorectal cancers are rectum cancers. Thepercentage of local disease stage is 39%, and the 10-year survival rate in such patients is approximately 90%. The aim of our studywas to evaluate the relationship between the clinicopathological characteristics and survival of patients with rectal cancer.Material and Methods: Patients who had undergone surgical treatment for rectal cancer in our clinic between January 2008 andDecember 2013 were evaluated retrospectively. The effects of clinicopathological parameters of these patients on survival wereinvestigated. The preoperative and postoperative variables were evaluated together with survival data.Results: Of the 70 patients, 30 (43%) were females and 40 (57%) were males. The median age was 61 years (min-max = 29-87 years).Eight of the patients (6%) were operated under emergency conditions due to acute abdomen or ileus. 13 (19%) of the patients hadundergone laparoscopic surgery and 57 (81%) had undergone open surgical resection. 15 patients (21%) had undergone anteriorresection (AR), 51 (73%) had lower anterior resection (LAR) and 4 (6%) had abdomino-perineal resection (APR). According to pTNMstaging, 6 patients (8%) were at stage-0, 7 (10%) were at stage-I, 22 (32%) were at stage-II, 26 (37%) were at stage-III, and 9 (13%)were at stage IV.Conclusion: We found that the ASA (American society of Anesthesiologists) score height, final stage of the tumor and vascular(venous) invasion associated with overall survival

PDF

___

1. Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol 2005;16:481-8.
2. Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 2016;66:271-89.
3. SEER Stat Fact Sheet; colon and rectum. National Cancer Institute http://seer.cancer.gov/statfacts/html/colorect. html access date 28.06.2016
4. Nasiri S, Donboli K, Meysamie A, et al. Prognostic factors in survival of colorectal cancer patients after surgery. Colorectal Disease 2008;11:157-61.
5. Moghimi-Dehkordi B, Safaee A, Zali MR. Prognostic factors in 1,138 Iranian colorectal cancer patients. Int J Colorectal Dis 2008;23:683-8.
6. Ragg JL, Watters DA, Guest GD. Preoperative risk stratiication for mortality and major morbidity in major colorectal surgery. Dis Colon Rectum 2009;52:1296-303
7. Gallina S, Proposito D, Veltri S, et al. Colorectal cancer surgery. Analysis of risk factors in relation to incidence of morbidity and mortality. Chir Ital 2006;58:723-32.
8. Carpelan-Holmström M, Louhimo J, Stenman UH, et al. Estimating the probability of cancer with several tumor markers in patients with colorectal disease. Oncology 2004;66:296-302.
9. Locker GY, Hamilton S, Harris J, et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 2006;24:5313-27.
10. Andreola S, Leo E, Belli F, et al. Manual dissection of adenocarcinoma of the lower third of the rectum specimens for detection of lymph node metastases smaller than 5 mm. Cancer 1996;77:607-12.
11. Park YJ, Park KJ, Park JG, et al. Prognostic factors in 2230 Korean colorectal cancer patients: analysis of consecutively operated cases. World J Surg 1999;23:721-26.
12. National Comprehensive Cancer Network (NCCN) recommendations available online at http: //www.nccn.org/ professionals/physician_gls/f_guidelines.asp access date 15.12.2018
13. Brown G, Richards CJ, Bourne MW, et al. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution mr ımaging with histopathologic comparison. Radiology 2003;227:371-77.
14. Meyenberger C, HuchBöni RA, Bertschinger P, et al. Endoscopic ultrasound and endorectal magnetic resonance imaging: a prospective, comparative study for preoperative staging and follow-up of rectal cancer. Endoscopy 1995;27:469-79.
15. Valentini V, Glimelius B, Minsky BD. The multidisciplinary rectal cancer treatment: main convergences, controversial aspects and investigational areas which support the need for an european consensus. Radiother Oncol 2005;76:241- 50.
16. Madoff RD. Chemoradiotherapy for rectal cancer? When, why and how? N Engl J Med 2004;351:1790-92.
17. Berardi R, Maccaroni E, Onofri A, et al. Multidisciplinary treatment of locally advanced rectal cancer: A literature review. Expert Opin Pharmacoter 2009;10:1-14.
18. Willett CG, Lewandrowski K, Donnelly S, et al. Are there patients with stage I rectal carcinoma at risk for failure after abdominoperineal resection? Cancer 1992;69:1651-55.
19. den Dulk M, Marijnen CA, Putter H, et al. Risk Factors for Adverse Outcome in Patients With Rectal Cancer Treated With an Abdominoperineal Excision in the Total Mesorectal Excision Trial. Ann Surg 2007;246: 83-90.
20. Jeong SY, Park JW, Nam BH, et al. Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial. Lancet Oncol 2014;15:767-74.
21. Bonjer HJ, Deijen CL, Abis GA, et al.; COLOR II Study Group. A randomized trial of laparoscopic versus open surgery for rectal cancer.NEngl J Med 2015;372:1324-32.
22. Stevenson AR, Solomon MJ, Lumley JW, et al. Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the aLaCaRT randomized clinical trial. JAMA 2015;314:1356-63.
23. Fleshman J, Branda M, Sargent DJ, et al. Effect of laparoscopic-assisted resection vs open resection of stage iI or III rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial. JAMA 2015;314:1346-55.
24. Leung KL, Kwok SP, Lam SC. Laparoscopic resection of rectosigmoid carcinoma: Prospective randomised trial. Lancet 2004;363:1187-92.
25. Gao F, Cao YF, Chen LS. Meta-analysis of short-term outcomes after laparoscopic resection for rectal cancer. Int J Colorectal Dis 2006;21:652-56.
26. Alvarez JA, Baldonedo RF, Bear IG, et al. Presentation, treatment, and multivariate analysis of risk factors for obstructive and perforative colorectal carcinoma. Am J Surg 2005;190:376.
27. Compton CC, Fielding LP, Burgart LJ, et al. Prognostic factors in colorectal cancer: College of American pathologists consensus statement 1999. Arch Pathol Lab Med 2000;124:979-94.
28. Tepper JE, O’Connell MJ, Niedzwiecki D, et al. Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol 2001;19:157-63.
29. Chang GJ, Rodriguez-Bigas MA, Skibber JM, et al. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst 2007;99:433- 41.
30. Ferenschild FT, Dawson I, de Wilt JH, et al. Total mesorectal excision for rectal cancer in an unselected population: quality assessment in a low volume center. Int J Colorectal Dis 2009;24:923-29.
31. Liebig C, Ayala G, Wilks J, et al. Perineural invasion is an independent predictor of outcome in colorectal cancer. J Clin Oncol 2009;27:5131-37.
32. Lim SB, Yu CS, Jang SJ, et al. Prognostic significance of lymphovascular invasion in sporadic colorectal cancer. Dis Colon Rectum 2010;53:377-84.
33. Wolmark N, Fisher B. An analysis of survival and treatment failure following abdominoperineal and sphincter-saving resection in Dukes’ B and C rectal carcinoma. A report of the NSABP clinical trials. National Surgical Adjuvant Breast and Bowel Project. Ann Surg 1986;204:480-9.
34. Vernava AM, 3rd, Moran, M, Rothenberger, DA, et al. A prospective evaluation of distal margins in carcinoma of the rectum. Surg Gynecol Obstet 1992;175:333-37.
35. Williams, NS, Dixon, MF, Johnson, D. Reappraisal of the 5 centimetre rule of distal excision for carcinoma of the rectum; a study of distal intramural spread and of patients’ survival. Br J Surg 1983;70:150-4.
36. Macadam R, Yeomans N, Wilson J, et al. Factors af-fecting morbidity, mortality and survival in patients undergoing surgery for rectal cancer in a district general hospital. Ann R Coll Surg Engl 2005;87:334-8.
37. Cerottini JP, Caplin S, Pampallona S, et al. Prognostic factors in colorectal cancer. Oncol Rep 1999;6:409-14.
38. Davila JA, Rabeneck L, Berger DH. Postoperative 30-day mortality following surgical resection for colorectal cancer in veterans: changes in the right direction. Dig Dis Sci 2005;50:1722-28.